Sponsor:
Mayo Clinic
Code:
NCT05856136
Conditions
Respiratory Function Loss
Respiratory Complication
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fentanyl Injection
Brief summary:
Conditions
Respiratory Function Loss
Respiratory Complication
Study ID
NCT05856136
Start date
Jun 19, 2023
Status verified date
Jun, 2026
Completion date
Jan 1, 2027
Anticipated
Primary completion date
Dec 8, 2025
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
69 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Basic Science
Arms
experimental: Ultrasound Shear Wave Elastography Examination - Lower
experimental: Ultrasound Shear Wave Elastography Examination - Mid
experimental: Ultrasound Shear Wave Elastography Examination - Higher
Interventions
Fentanyl Injection
Primary outcome measure
Locations
Mayo Clinic Minnesota
Recruiting
Rochester, Minnesota, United States, 55905
Contacts
Sponsor
Mayo Clinic
Last update posted
Jun 23, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2026-06-23.